Travis Kalanick Sees Benefits of Stealth Mode for 8 Years
Eight years in stealth have shaped a new robotics venture from Travis Kalanick, with implications for workers, equity...
Which High Cash Back Cards Have No Annual Fee
Uncover the best high cash back cards that charge no annual fees. Maximize your rewards while keeping your costs down.
28,270 articles
Utility ETFs Soar Power as AI Demand Lifts Sector Momentum
AI-driven data centers are lifting utility ETFs higher as power demand climbs. This report analyzes leading funds and...
Stocks Sink as Market Digests Oil Rally to $110 Today
U.S. equities fell Friday as oil surged to $110 a barrel, stoking inflation worries and shaping expectations for mone...
IMAX, SHARKNINJA, SONOS: Which Stock Shines in March
In March 2026, investors weigh IMAX, SHARKNINJA, and SONOS as each pushes growth through screens, margins, and softwa...
Alphabet (GOOG) Just Shakes Markets with 100-Year Bond Move
Alphabet reportedly priced a rare 100-year bond to back AI and data-center expansion, a move that stirs debate on lon...
Whirlpool Stock Down Outlook: Buy, Sell, or Hold in 2026
Whirlpool faces a challenging 2026 as costs rise and demand shifts. This guide breaks down the whirlpool stock down o...
Could Ignite Solar Stock Rally Amid Policy Hurdles Today
Policy headwinds aren’t the end of the story for solar investors. This guide explains how AI-driven demand, select co...
Why the World Carvana Betting Stellantis? A Deep Dive
Carvana, known for online used-car sales, is making a curious bet on Stellantis. This article explains the rationale,...
Midwest Multifamily Investment Sector Heating BAM Capital
Midwest apartment markets are turning brighter as rents rise and debt costs ease. BAM Capital now offers accredited i...
Hims Hers Stock Drops: Is This a Buy or Warning Sign?
When a stock slides after earnings, it can signal trouble or opportunity. This article dives into why hims hers stock...
Lucid Stock Deeply Oversold Sparks 40% Upside
Lucid stock deeply oversold scenarios meet a potential production ramp and strategic partnerships that could unlock m...
AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status